FENNEC PHARMACEUTICALS INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
FENNEC PHARMACEUTICALS INC. (FENC) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$8.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-27
- FENNEC PHARMACEUTICALS INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was -$8.00K.
- FENNEC PHARMACEUTICALS INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $432.00K, a 14.29% decline from fiscal 2021.
- FENNEC PHARMACEUTICALS INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $504.00K, a 68.56% increase from fiscal 2020.
- FENNEC PHARMACEUTICALS INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2020 was $299.00K, a 6.03% increase from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$8.00K 10-K · filed 2026-03-27 | |
| 2022-12-31 | $432.00K 10-K · filed 2023-03-29 | |
| 2021-12-31 | $504.00K 10-K · filed 2023-03-29 | |
| 2020-12-31 | $299.00K 10-K · filed 2022-02-28 | |
| 2019-12-31 | $282.00K 10-K · filed 2021-03-30 | $280.00K 10-K · filed 2020-02-14 |
| 2018-12-31 | $55.00K 10-K · filed 2020-02-14 | |
| 2017-12-31 | $63.00K 10-K · filed 2019-03-15 | |
| 2016-12-31 | -$1.00K 10-K · filed 2018-03-28 | |
| 2015-12-31 | $4.00K 10-K · filed 2017-03-29 | |
| 2014-12-31 | -$13.00K 10-K · filed 2016-03-28 | |
| 2013-12-31 | $222.00K 10-K · filed 2015-03-31 | |
| 2012-12-31 | $36.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |